Arrevus Inc.

Industry · 5 registered clinical trials.

Status	Trial	Phase	Started
Completed	Oral ARV-1801 Given in Combination With Intravenous Ceftazidime or Meropenem for Treatment of Melioidosis in H Melioidosis	Phase 2	2022-06-14
Completed	Oral Sodium Fusidate (CEM-102) for the Treatment of Staphylococcal Bone or Joint Infections Refractory Bone or Joint Infections	Phase 2 / Phase 3	2015-12-01
Completed	Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Struct Acute Bacterial Skin and Skin Structure Infections	Phase 3	2015-11-01
Terminated	Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint In Prosthetic Joint Infections of Hip, Prosthetic Joint Infections of Knee, Infected Spacers	Phase 2	2012-12-01
Completed	Safety and Efficacy of CEM-102 Compared to Linezolid in Acute Bacterial Skin Infections Skin Diseases, Bacterial	Phase 2	2009-08-01